The Hepatitis B Vaccine Market is expanding rapidly, driven by global efforts to reduce the burden of hepatitis-related diseases. Increasing awareness of liver disorders, government vaccination mandates, and enhanced healthcare infrastructure in emerging economies are contributing to market growth. Vaccine manufacturers are introducing cost-effective and easy-to-administer formulations to...